CVS Subsidiary Omnicare Initiates Chapter 11 for Restructuring or Sale Strategy
Reuters
Sep 23
CVS Subsidiary Omnicare Initiates Chapter 11 for Restructuring or Sale Strategy
Omnicare, LLC, a subsidiary of CVS Health, has initiated a voluntary Chapter 11 process in the U.S. Bankruptcy Court for the Northern District of Texas. The company aims to address financial challenges and recent litigation issues through a standalone restructuring or sale strategy. To support this process, Omnicare has secured $110 million in debtor-in-possession financing, pending court approval, to ensure sufficient liquidity for operations. The company remains committed to providing reliable pharmacy services and optimal care to its customers and residents during this period. Legal and financial advisors involved in the process include Jenner & Block LLP, Haynes Boone, Houlihan Lokey, and Alvarez & Marsal. Additional information and court filings can be accessed online through Omnicare's dedicated restructuring websites.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: NE80256) on September 22, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.